dc.contributor.author | Pramod Kumar | |
dc.contributor.author | Pradeep Krishna | |
dc.contributor.author | Maidur, Rohit N. | |
dc.contributor.author | Naveen Chandrashekhar | |
dc.contributor.author | Suresh Raghavaiah | |
dc.date.accessioned | 2025-01-20T10:01:56Z | |
dc.date.available | 2025-01-20T10:01:56Z | |
dc.date.issued | 2024-11 | |
dc.identifier.citation | Journal of Liver Cancer. 2024 November; | en_US |
dc.identifier.issn | 2288-8128 | |
dc.identifier.uri | http://dspace.sdmucmsh.edu.in:8080/xmlui/handle/123456789/2341 | |
dc.language.iso | en | en_US |
dc.publisher | Korean Liver Cancer Association | en_US |
dc.subject | Cirrhosis | en_US |
dc.subject | Hepatocellular carcinoma | en_US |
dc.subject | Immunotherapy | en_US |
dc.subject | Liver transplantation | en_US |
dc.title | Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report | en_US |
dc.type | Article | en_US |